Review article · 2016
Conference abstractPublished 2020
FORCE IN LONG TERM IMMUNO_SUPPRESSION
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Extended Abstract Sepsis is defined as the host inflammatory response to severe, life-threatening infection, with the presence of biochemical abnormalities and organ dysfunction. It is a major healthcare problem, affecting millions of people around the world every year. Its incidence is increasing owing to the ageing population, immuno-senescence and the resulting impaired immunity. Moreover, it is the most frequent cause of mortality in most intensive care units (ICUs), especially if not recognized and treated promptly [1]. Despite its worldwide importance and being considered a public health concern, accounting for more than $20 billion (5.2%) of total US hospital costs in 2011 [2] public awareness of sepsis is poor. The short-term mortality of sepsis is 10-40% and even higher for septic shock (30-60%). Most clinical studies examining patients with sepsis have used 28 day mortality as a clinical end point, and although only a few studies on long-term mortality exist, they indicate that long-term mortality is also increased among patients who had survived the acute episode of severe sepsis septic event, even after accounting for their underlying medical comorbidities. Recent data demonstrate that survivors have poor quality of life, frequently develop cognitive and functional disability, and require substantial ongoing acute and long term care [5]. In addition, higher long term mortality has been reported in patients with community-acquired severe sepsis or septic shock, as compared to individuals of similar age, sex and comorbidities [6]. Possible causes for the long-term impairments observed include hypoperfusion, toxins, maximal stress response (cytokines), exposure to treatments (such as steroids), immobility, development of complications such as acute lung injury or combinations of these and other factors. The current paradigm regarding the host immune response to sepsis is under debate [7-11]. Some theories are being considered in order to explain the nefarious consequences of sepsis on the survivors. The most recent and accepted theory states that sepsis consists on an initial hyper-inflammatory phase which can produce “early” deaths during the first 24 h-48 h (e.g. in the toxic shock). Two other theories, based on the immune response, try to explain the morbi-mortality and “late deaths” induced by sepsis few days after hyper-inflammatory phase. The first relies on a persistent activation of innate immunity that would lead to hyperinflammation, which in turn may cause multiple organ dysfunctions [12]. The second theory - and most widely supported - proposes that after an initial phase of hyper-inflammatory response, a failure or exhaustion of adaptive immunity (T-lymphocytes) occurs, that produces immuno-paralysis or immunosuppression (Figure 1). This phase of immunosuppression produces late deaths due to the exhausted immune response and the apparition of new opportunistic or recurrent infections [8].
Keywords
Subjects
Genetics & Molecular BiologySimilar by topic
Short communication · 31 Aug 2020
The tumor-suppressive role of mesenchymal stem cells in cancer-resistant and long-lived subterranean rodent,Spalax
Mini review · 28 Oct 2021
Azathioprine: An Immuno-Suppressant Drug Used to Prevent Kidney Rejection after Transplant
Conference abstract · 29 Jun 2021
What kind of patient are we hospitalizing in the hospital: Immuno competent or immune suppressed?
Conference abstract · 22 May 2017
Development of an immuno-suppressive agent, Cyn-1324 for treating with asthma
More from this journal
The newest in Journal of Clinical Epigenetics.
Article · 30 Dec 2024
Epigenetic Therapies in Critical Care: A Future Perspective
Article · 30 Dec 2024
Nutritional Factors Affecting Epigenetic Regulation in ICU Patients
Article · 30 Dec 2024
Epigenetic Changes in Hypoxia in Critically Ill Patients
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Epigenetics
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Jose Luis Garcia Gimenez”
